Navigation Links
Helix BioPharma shareholders vote in favour of management
Date:1/30/2008

Helix BioPharma Corp. (TSX: HBP / Frankfurt: WKN 918864)

AURORA, ON, Jan. 30 /PRNewswire-FirstCall/ - Helix BioPharma Corp. announces that at the Company's Annual General Meeting held on January 29th, 2008, shareholders adopted all of the resolutions presented by management, appointing KPMG LLP as auditor, electing Don Segal, John Docherty, Ken Cawkell, Jack Kay, Slawomir Majewski, and Gordon Lickrish as directors, and approving certain amendments to the Company's by-laws.

Joining the Helix BioPharma board is Professor Slawomir Majewski, Head of the Department of Dermatology and Venereology at the Warsaw School of Medicine in Poland. Professor Majewski's extensive experience in the field of dermatology, and especially sexually transmitted diseases and skin cancer, will be of great benefit to the Board of Directors and the senior management team at Helix.

Retiring from Helix's board are Conor Gunne and Dr. Richard Rossman, who served as directors of Helix for a number of years. "I would like to personally thank both Conor and Richard for their valuable contribution to the Company over the many years and wish them both well in their other endeavors," said Don Segal, CEO of Helix BioPharma.

Helix's management would also like to thank its shareholders for their continued support, and looks forward to the further development of the Company's new drug products, Topical Interferon Alpha-2b and L-DOS47, in the year ahead.

A Report of Voting Results in respect of the Meeting will be posted on the SEDAR website at (http://www.sedar.com).

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon A
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...local and national radio advertising for small bus... and its Audio Ads network includes hundreds of ra...t mean for marketers who need to create a radio ad.... , ,"Over the last year, we,ve been partnering wi...cross the U.S. so that our advertisers have many o...
...Mexico-based biotechnology company, has selected t...o manufacture its DNA-based, pre-flu vaccine. , ... Waisman Center , the biomanufacturing facility is... pharmaceutical products for Phase I and II human ...ials underway before the end of next year,s flu se...
...w strategic plan featuring enhancements to 25 rout...s announced the launch of nonstop Midwest Connect ..., the airport that serves Research Triangle Park ... fending off a hostile takeover bid by AirTran Hol...equested destination of business travelers because...
...ered the spawning ground for the next wave of high...growth in the national angel market, a diversified...ional investors. , ,In its 2006 Angel Market Anal...niversity of New Hampshire reports that angel inv...al investments of $25.6 billion. , ,A report on 2...
Other Biology Technology:See how they run: Radio ads and Google 2See how they run: Radio ads and Google 3See how they run: Radio ads and Google 4National angel investment grew 11 percent in `06 2National angel investment grew 11 percent in `06 3
(Date:9/5/2008)...work as recently illustrated by the flightless and...a. This cricket relative is found in New Zealand a...ales weighing in at 20 g, averaging twice the size...aland, published in the September issue of The Am...he University of Toronto at Mississauga discovered...
(Date:9/5/2008)... challenge of surviving in a changing climate. Res...Claude Bernard Lyon have shown how a sheep populat...and responds to two consequences of climate change...ty of winter storms. Dr. Thomas Ezard, lead author...food is plentiful, lambs contribute almost twice a...
(Date:9/5/2008)...nies of a critically endangered vulture, whose num...ns to a few thousand, are too small to protect the... analysis shows. , Adding wild birds to the capt...ucial, but political and logistical barriers are h.... , The study was published online August 15 in ...
(Date:9/5/2008)...e Gustav is shown via a sequence of satellite imag... Spectrometer (MERIS) instrument on 25 August, 28 ... to left). , Gustav formed on 25 August 2008 som...above far right image), when a tropical wave devel...visible), causing the U.S. National Hurricane Cent...
Breaking Biology News(10 mins):Lightweight and long-legged males go the distance for sex 2Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3Hurricane Gustav 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 1Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 3Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 1Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 1Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 4Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 1Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 2Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 3
...er blood vessels within the tissue of previously e...ignificant improvement in heart function. The stu... , With heart disorders affecting individuals glo...es, there has been a need to develop new treatment...ield of tissue engineering is to produce blood ves...
...ts will be the first in the area to insert a new t...hink of it as a contact lens inside your eye," sai...lantable collamer lens, or ICL, today for the firs... The ICL can replace or reduce the need for glasse...ficial lens in front of the eye,s natural lens, ra...
...ed breakdown of myelin, the fatty insulation coati...y with the presence of a key genetic risk factor f...in the January edition of the peer-reviewed journa...ing body of evidence that myelin breakdown is a ke...ter in life. , In addition, the study demonstrate...
...report describing the occurrence of pesticides in ...ort concludes that pesticides are typically presen... agricultural areas of the Nation, but are less co...hat pesticides are seldom at concentrations likely...cularly those draining urban and agricultural area...
Other Biology News:New 'implanted contacts' designed to fix nearsightedness 2Imaging study links key genetic risk for Alzheimer's disease to myelin breakdown 2Pesticides in the nation's streams and ground water 2Pesticides in the nation's streams and ground water 3Pesticides in the nation's streams and ground water 4
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8
Selenoprotein P Purified Anti-Mouse clone 35, Isotype Mouse IgG 2b , 50 µg Consult technical datasheet for details.
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications).
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate
Biology Products: